|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-4-20
|
|
pubmed:abstractText |
Cardiovascular disease is the primary complication and cause of death in patients with type 2 diabetes mellitus. Modification of cardiovascular risk factors may improve patient outcomes.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1539-3704
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
140
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
650-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15096337-Anticholesteremic Agents,
pubmed-meshheading:15096337-Cardiovascular Diseases,
pubmed-meshheading:15096337-Cholesterol, LDL,
pubmed-meshheading:15096337-Diabetes Mellitus, Type 2,
pubmed-meshheading:15096337-Diabetic Angiopathies,
pubmed-meshheading:15096337-Evidence-Based Medicine,
pubmed-meshheading:15096337-Female,
pubmed-meshheading:15096337-Humans,
pubmed-meshheading:15096337-Hypercholesterolemia,
pubmed-meshheading:15096337-Male,
pubmed-meshheading:15096337-Primary Prevention,
pubmed-meshheading:15096337-Risk Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.
|
|
pubmed:affiliation |
Veterans Affairs Health Services Research and Development Center for Practice Management and Outcomes Research, University of Michigan, Ann Arbor 48105, USA. svijan@umich.edu
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
